Cardio-TriTest vs QIR Suite
AI Verdict
Choose Cardio-TriTest if…
Choose Cardio-TriTest if your primary goal is early and comprehensive cardiovascular disease detection directly in a primary care setting. This device is ideal for non-invasive, synchronized acquisition and visual correlation of real-time ECG, PCG, and MCG bio-signals for initial patient assessment and screening.
View Cardio-TriTest →Choose QIR Suite if…
Choose QIR Suite if you require advanced, quantitative analysis of existing MR and CT cardiovascular images to support detailed diagnosis and prognosis. This software excels at automatically segmenting heart regions, quantifying over 100 clinical parameters, and detecting pathological volumes for in-depth evaluation of complex conditions.
View QIR Suite →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardio-TriTest | QIR Suite |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | On-premise (device) | Locally on dedicated hardware |
| FDA Status | Unknown | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardio-TriTestCardio-TriTest (Tool A) appears to be more user-friendly for its target audience of primary care physicians, offering a quick, non-invasive, 10-minute test with immediate, visually correlated reports. While QIR Suite (Tool B) emphasizes optimized ergonomics for specialists, the inherent complexity of advanced imaging analysis makes Tool A's integrated point-of-care device more broadly accessible for routine use in primary care settings.
Clinical Value
Cardio-TriTestBoth tools offer significant clinical value in their respective domains. However, Cardio-TriTest (Tool A) provides a novel 3-in-1 diagnostic approach for earlier and more comprehensive cardiovascular disease detection in primary care, with validated 'echo-grade insights' for various heart conditions. This addresses a broader initial diagnostic need, bridging the gap between standard ECG and echocardiography.
Pricing & Value
QIR SuiteBoth tools require contacting the company for pricing, limiting transparency. However, QIR Suite (Tool B) provides a slight advantage by specifying potential pricing models (one-time license fee or subscription), which offers more insight into potential cost structures than Cardio-TriTest's (Tool A) generic 'contact for pricing' statement.
Enterprise Readiness
Cardio-TriTestCardio-TriTest (Tool A) explicitly states HIPAA compliance, which is a critical and foundational requirement for healthcare enterprises handling patient data in the US. While QIR Suite (Tool B) has multiple international clearances and ISO certification, the lack of explicit HIPAA compliance or a Business Associate Agreement (BAA) in its specifications presents a significant hurdle for enterprise adoption in the US market.
Innovation
Cardio-TriTestCardio-TriTest (Tool A) demonstrates a more disruptive innovation by integrating and synchronizing three distinct bio-signals (ECG, PCG, MCG) into a single, non-invasive device for comprehensive cardiac assessment at the point of care. While QIR Suite (Tool B) utilizes advanced AI for quantitative imaging analysis and claims a 'world first' for myocardial infarction evaluation, Tool A's multi-modal biosignal fusion represents a more fundamental shift in initial diagnostic methodology.
Support & Docs
Cardio-TriTestNeither tool provides extensive public details on dedicated customer support channels or comprehensive documentation portals. However, Cardio-TriTest's (Tool A) website explicitly offers options to 'Book a live demo' and 'Download the peer-reviewed white-paper,' indicating more readily available resources for engagement and product understanding.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardio-TriTest | QIR Suite |
|---|---|---|
| Tool Name | Cardio-TriTest | QIR Suite |
| Company | Cardio-Phoenix Inc. | CASIS Cardiac Simulation & Imaging Software |
| Primary Function | AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG for earlier and more comprehensive cardiovascular disease detection. | AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images. |
| Diagnostic Modalities/Input | ECG, PCG, MCG | MR and CT images |
| Key Analysis Capabilities | Synchronized bio-signal acquisition, visual correlation of heart bio-signals, AI-powered analysis for heart disease detection. | AI-based analysis of MR and CT examinations, detection of heart regions and pathological areas, quantification of over 100 clinical parameters, automatic segmentation, blood flow/velocities quantification, pathological volumes detection and quantification, semi-quantification of myocardial perfusion, strain quantification. |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Cardio-TriTest and QIR Suite.